Latest filing published 04 Sept 2024 for Calliditas Therapeutics AB, €248k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Diane Parks: trading record in brief
Diane Parks discloses dealings in Calliditas Therapeutics AB to Finansinspektionen. Between 16 August 2022 and 2 September 2024, the trades on record add up to 3 filings.
On the market, this insider has only sold: 1 sale, €248k in total. Other entries cover 2 share grants. Since January 2024: no purchases and 1 sale on the market.
The newest entry dates from 4 September 2024: an open-market sale of €248k, in Calliditas Therapeutics AB. The median gap between a trade and its publication by Finansinspektionen is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Diane Parks
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,535 shares@ SEK 208.00100.0% of flowAktieISIN SE0010441584FI:csv-44724ce31b8766b9b609
- 4,086 shares0AktieISIN SE0010441584FI:csv-06db29ea8af76be48206
- 8,449 shares0AktieISIN SE0010441584FI:csv-b90397e5844429135d68
3 of 3 declarations